Vitamin C prevents cigarette smoke induced atherosclerosis in guinea pig model

J Atheroscler Thromb. 2010 Aug 31;17(8):817-27. doi: 10.5551/jat.2881. Epub 2010 May 13.

Abstract

Aim: Cigarette smoking is a major risk for developing atherosclerosis; however, the underlying mechanism is poorly understood. This paucity of knowledge is largely attributed to the lack of an animal model; therefore, our efforts were targeted towards establishing cigarette smoke (CS)-induced atherosclerosis in guinea pig. To understand the mechanism, we investigated apoptosis, an event implicated in atherosclerosis, in the aorta of CS-exposed animals. Since a major deleterious effect of CS is oxidative stress, we also examined the effect of vitamin C, an antioxidant, on CS- induced atherosclerosis.

Methods and results: Guinea pigs on a diet with or without vitamin C supplement were exposed to CS for different time periods. Aortal sections from these animals were examined for atherosclerotic changes by staining with H&E and Oil red O. Atherogenic changes were observed in sections obtained from CS-exposed guinea pigs only. TUNEL assay showed the occurrence of apoptosis in CS-exposed guinea pig aorta. Our results revealed that CS-induced apoptosis could contribute to the progression but not to the initiation of the disease. Immunohistochemical analysis documents that CS-induced apoptosis in aortal sections is mediated at least in part by an increased Bax/Bcl2 ratio. In contrast, CS-exposed guinea pigs fed with vitamin C-supplemented diet exhibit little or no atherogenic changes. This anti-atherosclerotic activity of vitamin C can be attributed partly to its ability to inhibit CS-induced apoptosis and platelet activation.

Conclusion: Exposure of guinea pigs to cigarette smoke causes the development of atherosclerosis, which can be prevented by vitamin C supplement.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / therapeutic use*
  • Aorta / drug effects
  • Apoptosis / drug effects
  • Ascorbic Acid / therapeutic use*
  • Atherosclerosis / etiology
  • Atherosclerosis / prevention & control*
  • Dietary Supplements
  • Disease Models, Animal
  • Guinea Pigs
  • Immunoenzyme Techniques
  • In Situ Nick-End Labeling
  • Male
  • Oxidative Stress / drug effects
  • Platelet Activation / drug effects
  • Smoking / adverse effects*

Substances

  • Antioxidants
  • Ascorbic Acid